Skip to main content
Fig. 1 | BMC Endocrine Disorders

Fig. 1

From: Notoginsenoside R1 can inhibit the interaction between FGF1 and VEGFA to retard podocyte apoptosis

Fig. 1

NGR1 has a therapeutic target of DN A: Differential analysis of glomerular samples of DN based on lemma packet; B, C: Differential gene function (GO) and signal pathway analysis (KEGG) of glomerular samples of DN; D, E: NGR1 and DN related differential gene Veen analysis; F-K:The changes of VEGFA, FGF1, ITGB5, SLC5A2, and BACE1 were verified based on GSE96804. *P < 0.05; **P < 0.01: ***P < 0.001

Back to article page